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Objective To quantify reporting errors, measure incidence of
postpartum haemorrhage (PPH) and define risk factors for PPH
(≥500 ml) and progression to severe PPH (≥1500 ml).
Design Prospective observational study.
Setting Two UK maternity services.
Population Women giving birth between 1 August 2008 and 31
July 2009 (n = 10 213).
Methods Weighted sampling with sequential adjustment by
multivariate analysis.
Main outcome measures Incidence and risk factors for PPH and
progression to severe PPH.
Results Errors in transcribing blood volume were frequent (14%)
with evidence of threshold preference and avoidance. The
incidences of PPH ≥500, ≥1500 and ≥2500 ml were 33.7% (95%
CI 31.2–36.2), 3.9% (95% CI 3.3–4.6) and 0.8% (95% CI 0.6–1.0).
New independent risk factors predicting PPH ≥ 500 ml included
Black African ethnicity (adjusted odds ratio [aOR] 1.77, 95% CI
1.31–2.39) and assisted conception (aOR 2.93, 95% CI 1.30–6.59).
Modelling demonstrated how prepregnancy- and
pregnancy-acquired factors may be mediated through intrapartum
events, including caesarean section, elective (aOR 24.4, 95% CI
5.53–108.00) or emergency (aOR 40.5, 95% CI 16.30–101.00), and
retained placenta (aOR 21.3, 95% CI 8.31–54.7). New risk factors
were identified for progression to severe PPH, including index of
multiple deprivation (education, skills and training) (aOR 1.75,
95% CI 1.11–2.74), multiparity without caesarean section (aOR
1.65, 95% CI 1.20–2.28) and administration of steroids for fetal
reasons (aOR 2.00, 95% CI 1.24–3.22).
Conclusions Sequential, interacting, traditional and new risk
factors explain the highest rates of PPH and severe PPH reported
to date.
Keywords Blood loss, observational study, pregnancy,
progression, risk factors, severe adverse maternal morbidity.
Please cite this paper as: Briley A, Seed PT, Tydeman G, Ballard H, Waterstone M, Sandall J, Poston L, Tribe RM, Bewley S. Reporting errors, incidence and
risk factors for postpartum haemorrhage (PPH) and progression to severe PPH: a prospective observational study. BJOG 2014;121: 876–888.
Introduction
Postpartum haemorrhage (PPH), defined as blood loss
≥500 ml, is a major cause of maternal mortality and mor-
bidity worldwide.1 For every death, 20 women live with the
consequences of associated morbidities,2 with the greatest
burden in low-income countries.3 PPH is a common emer-
gency, and readily treatable when appropriate resources are
available.4
Severe PPH (variously defined from 1000 ml upwards)
has been used as a measure of severe morbidity and is an
appropriate adjunct to mortality reports.4–6 In Europe, one
in eight maternal deaths are linked to PPH.7 In the UK,
despite the widespread availability of effective treatments
and guidelines, deaths from PPH still occur (9/107 direct
deaths in 2006–2008, 0.39/100 000 maternities; 95% CI
0.20–0.75).5 Additionally, for each death, 15 women
undergo hysterectomy.8
Despite surgical, medical and training innovations, PPH
rates remain high in several high-income countries includ-
ing the UK9–11 with an incidence of 13% recently reported,
and evidence that both PPH12 and severe PPH13 are
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increasing. The causes are likely to be multifactorial with
shifting demography and health status widely cited, e.g.
age, obesity, comorbidity, multiple pregnancy and ethnic-
ity,14–19 in addition to rising caesarean section rates.10,17,20
These suppositions require formal evaluation.
The quantification of blood loss remains problematic.
Although recognised as unreliable,21,22 the usual method is
visual assessment following minimal training.23 Accurate
estimation is critical because volume thresholds are used to
initiate treatment and resuscitation protocols. Despite this,
rigorous evaluation of those errors, which may reduce the
accuracy of estimated blood loss (EBL), has seldom been
attempted.24–26
This prospective observational study aimed to: (i) quan-
tify common EBL reporting errors; (ii) measure PPH inci-
dence; (iii) identify chronologically ordered risk factors
(pre-existing or acquired) for PPH and progression to
severe PPH.
Methods
This is the quantitative component of the mixed methodol-
ogy STOP (Surveillance and Treatment of Postpartum
haemorrhage) study. PPH management and qualitative
results will be reported separately.
A prospective observational study was undertaken in two
maternity services incorporating an inner London tertiary
referral teaching hospital and a district general hospital in
South East England.
Patients and data collection
The population studied comprised all women giving birth
between 1 August 2008 and 31 July 2009 (n = 10 213).
In both centres, maternity data were primarily docu-
mented in paper records that remained with the woman
throughout her pregnancy and early puerperium. Summary
data, transcribed from the notes, were entered onto elec-
tronic patient databases immediately following birth. This
procedure is widespread in UK maternity units.
For the study, blood loss and minimal demographic/
delivery data were imported within 1 week of birth from
the hospital clinical electronic databases (HealthwareTM and
EuroKingTM) to a secure, bespoke data management system
(MedSciNetAB). Preservation of anonymity, data handling
and storage were in compliance with the UK Data Protec-
tion Act 1988.
Weighted sample
Detailed review of all maternity records was impractical
and limited by resource and time constraints. Therefore a
weighted sample design (disproportionate stratified sam-
pling), commonly employed in national statistics, accoun-
tancy and business surveys, was adopted27,28 (see
Supporting information, Appendix S1 Supplementary
Methods).
Data extraction and analysis
Two researchers reviewed all clinical data from the original
handheld records to more accurately evaluate blood loss
and identify transcription errors. Additional information
was obtained from other electronic sources (blood transfu-
sion, routine haematology and ultrasound). Variation
between researchers of the total volume documented was
always <5%; and was always resolved by discussion.
Data analysis was performed using STATA, version 11.2
(Stata Corp, College Station, TX, USA). Summaries, esti-
mates and comparisons were calculated using proportional
weighting to adjust for the sampling plan.
Definitions
Study definitions, including the categorisation of PPH by
EBL are listed (see Supporting information, Table S1).
Estimation of errors in reported clinical data
Discrepancies were determined using three approaches: (i)
evaluating the frequency and magnitude of transcription
errors for EBL between paper and electronic records; these
were compared to calculated errors for maternal age, maternal
date of birth, mode of delivery, baby date of birth, time of
birth, sex and birthweight; (ii) cross-checking the observed
discrepancies; this was undertaken by two researchers and
decision was deferred to a third when required, and to the
study Chief Investigator (CI) if there was persistent disagree-
ment; (iii) independently re-examining every tenth set of notes
and related electronic records within the weighted sample.
Precise EBL was not recorded in 61/101 waterbirths
(including eight homebirths) but following review of these
notes, 57 were categorised within 0–499 ml and four within
500–999 ml.
Assessment of incidence of PPH
The incidence of PPH and all other analyses was calculated
after adjustment of the EBL categories following inspection
of the handheld records.
Determination of potential risk factors for PPH to
be assessed
A detailed list of potential risk factors was compiled with
the intention of determining which were associated with
increased blood loss or increased risk of PPH. This
included previously identified and potential risk factors
assessed in three sequential groups: (a) pre-pregnancy, (b)
during pregnancy, (c) labour and birth. These were further
subdivided into pre-defined subgroups arranged, as far as
possible, in the order they generally occur (Appendix S1:
Supplementary Methods).
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The ultimate causes, identified from group (a) may be of
public health importance, while intermediate and immediate
causes from groups (b) and (c) may have more clinical rele-
vance. The strength of this approach is that appropriately
adjusted estimates for both earlier and later predictors are
obtained. While earlier factors can possibly be confounders
for later events, the reverse does not apply. For example, age
influences multiple pregnancy, which is itself believed to be
a risk factor for caesarean section and blood loss. Age is
therefore a potential confounder of the effect of multiple
pregnancy, and multiple pregnancy is a potential con-
founder of the effect of caesarean section, but not vice versa.
Models were designed to investigate three clinically
important aspects of blood loss: (i) in all women, absolute
blood loss (ml) (linear regression) and (ii) PPH ≥ 500 ml
(logistic regression); (iii) in women with PPH ≥ 500 ml, the
risk of progression onto severe PPH ≥ 1500 ml (logistic
regression). These models address the three questions: ‘How
much blood is this woman likely to lose?’, ‘Is this woman at
risk of PPH (≥500 ml)?’ and ‘Having lost 500 ml, what is
the likelihood of this woman experiencing severe PPH
(≥1500 ml) requiring major intervention?’ (more fully
described in Appendix S1: Supplementary Methods).
Justification of study duration, population and
sample size
All births over a complete year were studied to eliminate
seasonal fluctuations. Population diversity was increased by
inclusion of two centres. As this observational study did
not assess the influence of a single risk factor or interven-
tion, a conventional power calculation was not undertaken.
Comparison with previous and contemporary
evidence
To examine time trends, comparison was undertaken with
historical data from a prospective population-based case–
control study of severe maternal morbidity, involving the
same NHS Trusts (1997/98),16 using present study PPH
definitions. Comparison of PPH ≥ 2500 ml was made
using the Scottish national morbidity audit for the same
time frame as the current study.13
Results
Population and demography
Following selection by weighting, 1897 case notes were
examined; two women had no documentation of blood
loss. Allowing for weighting, the sample represented 9939
women of whom 9937 (>99.9%) had sufficient data (Fig-
ure 1, STROBE diagram).
In the whole group, 60% were ≥30 and 26% were
≥35 years old. Almost 60% were White, with Black African
the largest minority ethnic group (17%). Over 37% were
overweight or obese, 39% lived in areas of highest depriva-
tion and 12% were cigarette smokers. Table S2 (see Sup-
porting information) shows population demography and
outcomes in women with and without PPH.
Estimated blood loss error in electronic clinical
records
Comparison with paper records revealed a 14% error rate
in recorded EBL. This compares with error rates of 0.5%
maternal age, 0.2% maternal date of birth, 2.0% mode of
delivery, 0.0% baby date of birth, 0.4% time of delivery,
0.4% sex and 2.0% birthweight.
Table 1 shows categories of PPH by EBL. Following
review of the paper records 207/1895 weighted sample were
re-categorised: 1688 (89.1%) were unchanged, 192 (10.2%)
were moved to a higher and 15 (0.8%) to a lower EBL cat-
egory; women with no electronically recorded EBL (131/
10213, 1.28%) were assigned to categories 0–499 ml
(n = 101), 500–999 ml (n = 19), 1000–1499 ml (n =6) and
≥1500 ml (n = 5).
There was a preference to record EBLs ending in 0, or as
multiples of 5, 10, 50 and 100. In the full cohort
(n = 10 213) disproportionate numbers of women had
documented blood loss at exact thresholds; 500 ml (8.4%),
1000 ml (2.1%), 1500 ml (0.8%), 2000 ml (1.5%) and
2500 ml (0.2%). At each threshold, volumes just under
(within 50 ml) were favoured over those just above.
PPH incidence
Following adjustment for transcription errors, 33.7% had a
PPH ≥ 500 ml, 3.9% ≥ 1500 ml and 0.82% ≥ 2500 ml
(Table 1).
Determination of risk factors for PPH and
progression to severe PPH
Unadjusted results for all 211 variables are given in the
Supporting information, Table S3, including tests for
changes in blood loss, PPH ≥ 500 ml and progression onto
severe PPH (≥1500 ml). Fifty predictors of PPH ≥ 500 ml
(ten prepregnancy, 15 during pregnancy and 25 intrapar-
tum) selected on the basis of unadjusted significance were
entered into the next stage of the PPH model. A different
50 predictors of progression to PPH ≥ 1500 ml (11 prepre-
gnancy, 15 during pregnancy and 24 intrapartum) were
similarly entered into the progression model.
Modelling according to chronological sequence
Table 2 summarises the prediction of PPH. It uses only
predictors significant before adjustment. Each column
shows the adjusted odds ratios from a single model. Col-
umn 1 deals with prepregnancy factors only (appropriate at
first antenatal appointment). Column 2 includes risk
factors arising during pregnancy (appropriate prelabour).
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Column 3 includes risk factors linked to labour and birth
(appropriate postpartum).
Only 15 factors remained significant postpartum. Black
African ethnicity, previous PPH, placenta praevia (anterior
and major), maximum birthweight, temperature per degree
>37°C, chorioamnionitis, instrumental delivery, elective
caesarean, emergency caesarean, retained placenta, interval
to suturing (time taken and unrecorded) increased risk.
Intramuscular Syntometrine and Syntocinon 40/50 IU
infusion were protective.
Eight variables significant in columns 1 or 2 are not sig-
nificant in column 3 (age, body mass index [BMI], assisted
conception, multiple pregnancy, ‘warning’ antepartum
haemorrhage, pre-eclampsia, antibiotics and multiparity
without previous caesarean). Their effects may be mediated
through the 15 significant factors (see Methods).
Table 3 deals similarly with risk factors for progression
to severe PPH (≥1500 ml) and Figure 2A,B show all signifi-
cant variables diagramatically.
Incidence of severe PPH in historical comparison
Numbers of births increased from 8329 to 10 213 (19.7% rise)
between 1997/9816 and 2008/09. Over this 11-year period,
there was a 3.4 (95% CI 2.7–4.3) risk ratio for PPH ≥ 1500 ml
(n = 93 versus n = 391) and an 8.3 (95% CI 4.0–17.1) risk
ratio for PPH ≥ 2500 ml (n = 8 versus n = 81).
Table 1. Estimated rates of blood loss as % in each category in
study population (allowing for weighted sampling)
Category Blood loss (ml) All (%) 95% CI
No PPH <500 66.3 63.8–68.8
PPH – All ≥500 33.7 31.2–36.2
PPH - Minor 500–999 24.3 22.0–26.6
PPH – Moderate 1000–1499 5.5 4.8–6.1
PPH – Severe 1500–1999 2.0 1.6–2.4
2000–2499 1.1 0.74–1.5
≥1500 3.9 3.3–4.6
≥2500 0.82 0.63–1.0
Key:EPR; Electronic patient record. nw; number of women represented by the
reviewed notes allowing for the weighted sampling.
Imported EBL
Missing/<25 ml
n = 133
Imported EBL
>1000 ml
n = 783 
Imported EBL
500–999 ml
n = 394
Imported EBL 
25–499 ml
n = 552
n = 552
nw = 6624
(12*552)
n = 394
nw = 2364 
(6*394)
n = 131
nw = 131
(1*131)
n = 783
nw = 783 
(1*783)
Identified only via 
blood transfusion
(25–999 ml)
n = 35
n = 35
nw = 35
(1*35)
1:1
All cases 
reviewed
Imported EBL from EPR for all deliveries
1 August 2008–31 July 2009
n = 10 213
Total in study
n = 1895
nw = 9937
EBL 500–999 ml
n = 427
nw = 2419
EBL <500 ml
n = 653
nw = 6585
EBL >1500 ml
n = 338
nw = 391
EBL >1000 ml
n = 815
nw = 933
EBL 1000–1499 ml
n = 477
nw = 542
1:12
Randomly 
selected cases 
reviewed
1:6
Randomly 
selected cases 
reviewed
Uncategorised
n = 2
nw = 2
1 unattended birth
1 attended by 
paramedic
Figure 1. STROBE diagram. Identification and classification of cases according to imported electronic patient records, recategorisation by blood loss
documented in handheld maternity notes and sample weighting.
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Table 2. Risk pathways for PPH ≥ 500 ml according to chronological variables grouped as prepregnancy, during pregnancy, labour and birth
Risk factors included in
final model
Pre-Pregnancy
Variable subgroups 1–4
(1895 women included)
OR (95% CI), p
During Pregnancy
Variable subgroups 1–10
(1868 women included;
27 excluded due to 1 missing data
and 26 perfectly predicted)
OR (95% CI), p
Labour and Birth
Variable subgroups 1–16
(1724 women included; 171 excluded
due to 135 missing data, 36 perfectly
predicted)
OR (95% CI), p
(1) Sociodemographic
Age, for each 10 years 1.45 (1.19–1.76), 0.000 1.44 (1.18–1.75), 0.000 0.93 (0.73–1.19), 0.57
Black African 1.77 (1.31–2.39), 0.000 1.77 (1.30–2.41), 0.000 1.94 (1.35–2.79), 0.000
(2) Local Deprivation: index of multiple deprivation, most deprived UK quintile (%)
Barriers – housing and services 1.06 (0.87–1.33), 0.61 1.05 (0.83–1.32), 0.69 1.04 (0.79–1.36), 0.80
Education, skills and training 0.93 (0.64–1.36), 0.72 0.93 (0.64–1.36), 0.71 1.03 (0.57–1.62), 0.89
(3) General and medical risk factors
Current smoker 0.76 (0.54–1.09), 0.14 0.77 (0.53–1.10), 0.15 0.82 (0.53–1.28), 0.38
BMI (kg/m2) per unit 1.03 (1.01–1.05), 0.006 1.03 (1.00–1.05), 0.016 1.01 (0.99–1.04), 0.32
Assisted conception 2.93 (1.30–6.59), 0.010 2.28 (0.99–5.29), 0.054 2.10 (0.83–5.33), 0.19
(4) Previous obstetric history
Previous PPH 2.34 (1.33–4.12), 0.003 2.45 (1.38–4.35), 0.002 2.75 (1.40–5.44), 0.003
Multiparous previous caesarean 1.32 (0.93–1.87), 0.19 1.30 (0.91–1.86), 0.14 0.96 (0.61–1.51), 0.86
Multiparous no previous
caesarean
0.33 (0.26–0.42), 0.000 0.33 (0.25–0.42), 0.000 0.79 (0.56–1.11), 0.18
(5) Current pregnancy
Multiple pregnancy 2.27 (1.04–4.96), 0.039 2.02 (0.82–5.00), 0.13
Admissions >24 weeks 0.82 (0.57–1.18), 0.28 0.82 (0.53–1.29), 0.39
(6) Antenatal day unit (ADU) attendances
Any ADU attendance 1.06 (0.84–1.34), 0.62 0.95 (0.72–1.26), 0.74
Pre-eclampsia screen 1.06 (0.65–1.75), 0.81 1.04 (0.57–1.91), 0.89
Generally unwell 1.22 (0.68–2.18), 0.50 1.33 (0.69–2.60), 0.40
(7) Placenta praevia: All 26 women with major or anterior placenta praevia PPH > 500 ml
(8) Antepartum haemorrhage (APH) and urinary tract infection
APH 1.11 (0.62–1.99), 0.74 1.27 (0.65–2.51), 0.48
‘Warning APH’ 8.95 (1.02–78.7), 0.048 1.92 (0.19–19.3), 0.58
(9) Pre-eclampsia (PET) and anaemia
Gestational hypertension 1.83 (0.83–4.03), 0.13 2.22 (0.87–5.63), 0.093
Pre-eclampsia 3.16 (1.12–8.93), 0.030 3.21 (0.94–10.90), 0.062
(10) Medications in pregnancy pre-birth
Antibiotics 1.35 (1.01–1.80), 0.043 1.14 (0.77–1.66), 0.52
Antihypertensives
(including for PET)
0.75 (0.44–1.29), 0.30 0.66 (0.33–1.32), 0.24
Diabetic Rx 1.89 (0.79–4.56), 0.15 1.20 (0.43–3.37), 0.73
Steroids for fetal reasons 0.90 (0.57–1.43), 0.65 1.23 (0.69–2.18), 0.49
(11) Gestation at birth
Gestation at delivery (weeks) 0.98 (0.90–1.08), 0.70
(12) Birthweight
Maximum birthweight (kg) 2.19 (1.62–2.99), 0.000
(13) Onset of labour
No labour onset 1.51 (0.47–4.90), 0.49
Induction 0.75 (0.39–1.46), 0.40
Augmentation 0.83 (0.42–1.64), 0.59
ROM > 2 hours before onset 0.95 (0.64–1.41), 0.79
ROM > 6 hours before onset 1.35 (0.90–2.02), 0.14
ROM not recorded 1.03 (0.60–1.77), 0.91
(14) Intrapartum: all ten women with evidence of chorioamnionitis PPH > 500 ml
Prostin 1.04 (0.53–2.02), 0.91
Syntocinon 1.44 (0.95–2.16), 0.085
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Incidence of severe PPH in contemporary cohort
The incidence of PPH ≥ 2500 ml was 0.82% (95% CI
0.63–1.0, n = 81/9937) compared with 0.56% (95% CI
0.49–0.62, n = 306/54910) in Scotland during the same
period.13
Discussion
Main findings
The incidences of PPH and severe PPH in the present
study are, to our knowledge, the highest reported from any
high-income or low-income country.1,3,9–12 The novel
application of weighted sampling highlighted errors
between clinical notes and electronic summary data. Estab-
lished and novel risk factors for both PPH and progression
to severe PPH have been quantified. Rigorous and chrono-
logical assessment of contributory factors illuminate the
complex multifactorial origin of recent rises in PPH.
Strengths and limitations
Strengths include prospective design and contemporaneous,
robust data collection, mitigating ascertainment bias.
Weighted sample design maintained statistical power and
overcame the limitations of case–control studies. Risk
assessment using chronological categories was preferable to
stepwise regression (Appendix S1: Supplementary Meth-
ods). Generalisability may be limited by the higher depriva-
tion (39% lowest quintile) and larger proportion of women
>30 years in the current cohort compared with contempo-
raneous maternity data for England and Wales (60% versus
47%),29 although obesity rates were similar to recent
national figures (15.2% versus 15.6%).30 Comparison with
UK maternal ethnic distribution was not feasible because
these data are not in the public domain.31 Historical com-
parison could have been influenced by different methodol-
ogies, changes in local service provision and shifting
population. Despite controlling for known confounding
variables, associations cannot necessarily be assumed to be
causal. Gynaecological history, intended place of birth and
degree of perineal trauma were not included.
Interpretation
Reporting errors
This is the first study, to our knowledge, to identify major
errors in blood loss reporting in electronic maternity records.
As these summary data form the sole source of information
regarding hospital admissions, treatment and management,
Table 2. (Continued)
Risk factors included in
final model
Pre-Pregnancy
Variable subgroups 1–4
(1895 women included)
OR (95% CI), p
During Pregnancy
Variable subgroups 1–10
(1868 women included;
27 excluded due to 1 missing data
and 26 perfectly predicted)
OR (95% CI), p
Labour and Birth
Variable subgroups 1–16
(1724 women included; 171 excluded
due to 135 missing data, 36 perfectly
predicted)
OR (95% CI), p
Spinal anaesthesia 0.87 (0.51–1.49), 0.60
Epidural analgesia 1.08 (0.71–1.65), 0.71
Raised temperature
(per degree >37.0°C)
2.62 (1.24–5.52), 0.011
Temperature not recorded 0.75 (0.50–1.11), 0.15
(15) Birth
Instrumental vaginal 3.50 (2.21–5.24), 0.000
Elective caesarean 24.4 (5.53–108.00), 0.000
Emergency caesarean section 40.5 (16.30–101.00), 0.000
(16) Third stage
Physiological 1.48 (0.80–2.77), 0.22
Syntometrine intramuscular 0.55 (0.33–0.91), 0.019
Syntocinon intravenous bolus 0.58 (0.27–1.25), 0.17
Syntocinon 40/50 IU infusion
commenced
0.61 (0.38 –0.99), 0.045
Retained placenta 21.3 (8.31–54.70), 0.000
Suture interval after vaginal
birth (hours)
2.03 (1.65–2.50), 0.000
Suture interval not recorded 2.2 (1.32–3.69), 0.003
Full regression model; result of three multiple regression models selecting the principal significant variables. In each model, an additional group of
predictors is added. Results adjusted for other members of the same group and for previous groups only.
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Table 3. Risk pathways for progression of PPH from ≥500 ml to severe PPH ≥ 1500 ml according to chronological variables grouped as
prepregnancy, during pregnancy, labour and birth
Risk factors included in final model
(1230 women included; 70 excluded due to missing
data in addition to all women with EBL<500 ml)
Prepregnancy
Variable subgroups 1–4
OR (95% CI), P
During pregnancy
Variable subgroups 1–10
OR (95% CI), P
Labour and birth
Variable subgroups 1–16
OR (95% CI), P
(1) Sociodemographic
Age, for each 10 years 0.85 (0.67–1.07), 0.16 0.90 (0.68–1.09), 0.20 0.99 (0.77–1.29), 0.96
Black African 0.86 (0.62–1.19), 0.36 0.84 (0.61–1.17), 0.31 0.91 (0.64–1.30), 0.61
(2) Local Deprivation: index of multiple deprivation, most deprived UK quintile (%)
Barriers to housing and services 0.79 (0.60–1.03), 0.076 0.78 (0.59–1.02), 0.069 0.75 (0.56–1.01), 0.055
Education, skills and training 1.75 (1.11–2.74), 0.015 1.84 (1.16–2.92), 0.009 1.82 (1.10–3.00), 0.019
(3) General and medical risk factors
Current smoker 0.59 (0.36–0.97), 0.039 0.56 (0.33–0.93), 0.026 0.67 (0.38–1.17), 0.16
BMI (kg/m2) per unit 1.03 (1.00–1.05), 0.022 1.03 (1.00–1.05), 0.023 1.04 (1.01–1.06), 0.008
Assisted conception 1.41 (0.79–2.50), 0.25 1.02 (0.53–1.93), 0.096 1.18 (0.60–2.35), 0.64
(4) Previous obstetric history
Previous PPH 1.79 (1.06–3.02), 0.030 1.93 (1.13–3.31), 0.016 2.39 (1.33–4.28), 0.003
Multiparous previous caesarean 0.70 (0.49–1.01), 0.055 0.63 (0.43–0.92), 0.018 0.84 (0.54–1.30), 0.43
Multiparous no previous caesarean 1.65 (1.20–2.28), 0.002 1.55 (1.12–2.16), 0.009 1.17 (0.80–1.74), 0.42
(5) Current pregnancy
Multiple pregnancy 2.00 (1.05–3.82), 0.035 2.60 (1.27–5.38), 0.009
Admissions >24 weeks 0.67 (0.44–1.02), 0.062 0.83 (0.53–1.32), 0.43
(6) Antenatal day unit (ADU) attendances
Any ADU attendance 1.17 (0.89–1.56), 0.26 1.05 (0.77–1.43), 0.75
Pre-eclampsia screen 0.93 (0.55–1.57), 0.80 1.15 (0.66–2.01), 0.62
Generally unwell 1.49 (0.82–2.70), 0.19 1.69 (0.90–3.20), 0.11
(7) Placenta praevia
Anterior 3.37 (0.86–13.30), 0.082 5.55 (1.29–23.9), 0.022
Major 0.72 (0.17–3.05), 0.660 0.97 (0.22–4.25), 0.97
(8) Antepartum haemorrhage (APH) and urinary tract infection
APH 1.26 (0.67–2.37), 0.48 1.25 (0.62–2.52), 0.53
‘Warning APH’ 1.70 (0.56–5.20), 0.35 1.99 (0.58–6.81), 0.27
(9) Pre-eclampsia (PET) and anaemia
Gestational hypertension 1.00 (0.47–2.16), 0.99 0.98 (0.43–2.22), 0.97
Pre-eclampsia (PET) 1.03 (0.43–2.50), 0.95 0.87 (0.32–2.13), 0.69
(10) Medications in pregnancy prebirth
Antibiotics 1.02 (0.74–1.40), 0.91 0.95 (0.65–1.39), 0.79
Antihypertensives (including for PET) 0.99 (0.56–1.78), 0.92 0.91 (0.49–1.70), 0.77
Diabetic Rx 0.98 (0.44–2.18), 0.96 1.23 (0.52–2.91), 0.64
Steroids for fetal reasons 2.00 (1.24–3.22), 0.004 2.00 (1.17–3.41), 0.011
(11) Gestation at birth
Gestation at delivery (weeks) 0.95 (0.86–1.04), 0.25
(12) Birthweight
Maximum birthweight (kg) 1.17 (0.87–1.59), 0.30
(13) Onset of labour
No labour onset 1.28 (0.54–3.03), 0.58
Induction 1.07 (0.56–2.04), 0.83
Augmentation 1.37 (0.73–2.58), 0.33
ROM >2 hours before onset 1.01 (0.60–1.70), 0.96
ROM >6 hours before onset 1.16 (0.73–1.85), 0.52
ROM unknown 0.95 (0.52–1.73), 0.86
(14) Intrapartum
Prostin 1.12 (0.60–2.11), 0.73
Syntocinon 0.75 (0.49–1.13), 0.17
Spinal anaesthesia 0.73 (0.45–1.18), 0.20
Epidural analgesia 1.20 (0.78–1.85), 0.41
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errors have implications for individual healthcare and policy.
Commonest errors were incorrect addition and failure to
include documented blood loss in totals, both in paper notes
and electronic records. The only relevant study, from 1994,
considered electronic data accurate, despite error rates of 5–
19%.32 Threshold avoidance and preference biases, although
identified for blood pressure33 and birthweight,34 have not
been previously reported for blood loss. Underestimation is
widespread for all birth modes,35 partly caused by visual
assessment23,36 although one study reports overestimation
following caesarean section.37 Our data confirm that
under-reporting remains unresolved.
Incidence
These PPH rates are higher than previous reports at every
threshold. Recent reports of rising rates,10,17,24,38 up to 13%
in high-income countries12 may be underestimates, because
most studies use routinely collected, retrospective and
‘coded’ electronic data.10,12,17,24,38–40 The incidence of
severe PPH ≥ 2500 ml is slightly higher than the contem-
poraneous Scottish audit,13 suggesting that they are real
underlying trends.
Risk factors for PPH, progression to severe PPH and risk
pathway modelling according to chronological sequence
Our approach differs from previous studies by highlighting
the need to consider underlying interlinked contributing
factors, which lead to PPH and contribute to the progres-
sion onto severe PPH.
Prepregnancy factors for PPH include age, ethnicity,
BMI, previous PPH and assisted conception. The associa-
tion with age is variably reported11,41–44 although older
women have more medical45 and obstetric46 comorbidities
and poorer uterine contractility.47 No previous study has
specifically identified Black African ethnicity as an indepen-
dent predictor,16–19,48 possibly because of lack of adjust-
ment for potential confounding variables.49–52 The
independent relationship between BMI and PPH concurs
with prospective cohort studies,14,53 although retrospective
and routine data reports are equivocal.54–56 The 4%
increase per BMI unit becomes substantial in higher obesity
categories. The new association with assisted conception
could reflect multiple pregnancy or abnormal placenta-
tion.57 The impact of previous PPH24,38 was confirmed,
and quantified, unlike previous caesarean section.58 Estab-
lished risk factors for severe PPH in the general population
included age, BMI, multiple pregnancy and previous cae-
sarean.14–16,54,55,59,60 However, our data did not highlight
any association with age, previous caesarean and severe
PPH. Although grand multiparity has been associated with
PPH,24 our data reveal multiparity as protective.38 The
unexpected findings that multiparity without caesarean sec-
tion and index of multiple deprivation (education, skills
and training) were risk factors for progression to severe
PPH require validation. Despite known associations with
placental abruption,61 the finding that smoking protects
against PPH progression may be associated with poor
uteroplacental blood flow.62
Table 3. (Continued)
Risk factors included in final model
(1230 women included; 70 excluded due to missing
data in addition to all women with EBL<500 ml)
Prepregnancy
Variable subgroups 1–4
OR (95% CI), P
During pregnancy
Variable subgroups 1–10
OR (95% CI), P
Labour and birth
Variable subgroups 1–16
OR (95% CI), P
Raised temperature (per degree >37.0°C) 1.21 (0.75–1.94), 0.44
Temperature not recorded 1.40 (0.86–2.27), 0.17
Chorioamnionitis 2.70 (0.70–10.5), 0.15
(15) Birth
Instrumental vaginal 0.79 (0.49–1.29), 0.36
Elective caesarean 0.14 (0.04–0.46), 0.001
Emergency caesarean section 0.34 (0.15–0.80), 0.013
(16) Third stage
Physiological 3.74 (1.72–8.10), 0.001
Syntometrine intramuscular 1.12 (0.66–1.91), 0.68
Syntocinon intravenous bolus 1.35 (0.63–2.87), 0.44
Syntocinon 40/50 IU infusion commenced 0.97 (0.65–1.44), 0.87
Retained placenta 1.40 (0.77–2.54), 0.27
Suture interval after vaginal birth (hours) 1.16 (0.99–1.35), 0.058
Suture interval not recorded 0.44 (0.25–0.79), 0.006
Full regression model: result of three multiple regression models selecting the principal significant variables. In each model, a new additional
group of predictors is used. Results are adjusted for other members of the same group and for previous groups only. Women with EBL <500 ml
are excluded.
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Confirmed pregnancy-acquired risk factors for PPH
include multiple pregnancy,9 placenta praevia,17
pre-eclampsia63 and macrosomia.64,65 The novel association
with prelabour antibiotic use could reflect chorioamnioni-
tis. Similarly, multiple pregnancy17 and anterior placenta
praevia were confirmed as predictors of progression to
severe PPH ≥ 1500 ml.16,17,66,67 The novel association with
administration of steroids for fetal reasons could be
explained by multiple pregnancy and threatened preterm
birth although gestation of delivery showed no effect. Over
62% of women with haemoglobin <8.5 g/l had PPH, 26%
of whom progressed to severe PPH, concurring with NICE
guidelines identifying this as a threshold for concern.68
Associations with third trimester anaemia using higher
thresholds were not confirmed.69,70
Confirmed intrapartum risk factors for PPH were tem-
perature,69 chorioamnionitis,64 instrumental and caesarean
births71,72 and retained placenta.65 We found no associa-
tion with induction and augmentation, agreeing with an
earlier report73 but at variance with others.12,47 Although
previously reported, the influence of caesarean59 and
retained placenta69,74 (adjusted odds ratio [aOR] 21.3)
were notable. Severe PPH is related to emergency caesar-
ean75,76 and the Royal College of Obstetricians and
A
B
Figure 2. Diagram of multiple logistic and chronological regression analysis showing (A) predictors of PPH ≥ 500 ml (protective factors in italics;
asterisks indicate perfect predictors, i.e. all women had PPH) and (B) predictors of PPH ≥ 500 ml onto severe PPH ≥ 1500 ml (protective factors in
italics).
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Gynaecologists state that it is less likely following elective
caesarean.76,77 We observed that both are strongly associ-
ated with PPH (aORs 24.4 and 40.5) but apparently pro-
tect against progression (aORs 0.14 and 0.34); however,
this is probably the result of prompt surgical and anaes-
thetic interventions. Prophylactic Syntometrine and
high-dose Syntocinon infusion were protective against
PPH, reinforcing concerns78 about current recommenda-
tions for intramuscular Syntocinon.79 Although not asso-
ciated with PPH, physiological third stage was a risk
factor for progression, possibly related to delays in recog-
nition or treatment, although others report <0.5% mater-
nal postnatal transfers.80 Time to complete genital tract
repair was confirmed as a risk for PPH.81
Conclusion
Identifying risk pathways is important as predisposing risk
can underlie factors that appear, accumulate and dominate
later events, including subsequent pregnancies.
These findings have implications for ‘red flags’, training
and emergency management. Currently, clinical tools are
only designed for PPH ≥ 500 ml.70 Clinicians must remain
vigilant, identify and respond to women’s accumulating
risks, recognise abnormal bleeding, summon assistance and
ensure prompt treatment and transfer. Staff must eschew
threshold preference and avoidance when assessing blood
loss, and keep scrupulous records of cumulative loss.
Prompt examination for genital tract trauma and expedient
suturing must be ensured. Although current practice
requires duplication of data entry,82 health professionals
should ensure accurate and complete transcription from
paper to electronic records.
Policy and research should tackle the potentially modifi-
able risk factors. Public health interventions addressing the
ageing reproductive population and obesity should be
encouraged. Commissioners must consider instrumental
and primary caesarean rates,38 which may depend on
informed decisions about staffing models83,84 and facilities
regarding planned place of birth.85 PPH is identified as a
key metric for quality of care86–88 yet this study emphasises
abundant flaws in measurement and reporting. Standard
procedures, including auditing the incidence of PPH and
accuracy of recorded EBL, must be improved, otherwise
reliance on EBL may be inappropriate.
Research should focus on the transferability of trauma
care innovations89,90 and implementation of clinical
improvements, such as cumulative blood loss recording,
training and reminders for staff.23,91,92 Weighted sampling
is an underused methodology that reduces data entry bur-
den and could be extrapolated to research, audit and moni-
tor other morbidities. Progression predictors and
attenuators might inform the design of an emergency strat-
egy to ameliorate severe PPH which otherwise looks set to
continue rising.
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